EC144 Is a Potent Inhibitor of the Heat Shock Protein 90

被引:54
|
作者
Shi, Jiandong [1 ]
Van de Water, Ryan [1 ]
Hong, Kevin [1 ]
Lamer, Ryan B. [1 ]
Weichert, Kenneth W. [1 ]
Sandoval, Cristina M. [1 ]
Kasibhatla, Srinivas R. [1 ]
Boehm, Marcus F. [1 ]
Chao, Jianhua [1 ]
Lundgren, Karen [1 ]
Timple, Noelito [1 ]
Lough, Rachel [1 ]
Ibanez, Gerardo [1 ]
Boykin, Christina [1 ]
Burrows, Francis J. [1 ]
Kehry, Marilyn R. [1 ]
Yun, Theodore J. [1 ]
Harning, Erin K. [1 ]
Ambrose, Christine [2 ]
Thompson, Jeffrey [2 ]
Bixler, Sarah A. [2 ]
Dunah, Anthone [2 ]
Snodgrass-Belt, Pamela [2 ]
Arndt, Joseph [2 ]
Enyedy, Istvan J. [2 ]
Li, Ping [2 ]
Hong, Victor S. [2 ]
McKenzie, Andres [2 ]
Biamonte, Marco A. [1 ]
机构
[1] Biogen Idec Inc, San Diego, CA 92122 USA
[2] Biogen Idec Inc, Cambridge, MA 02142 USA
关键词
HSP90; INHIBITOR; BREAST-CANCER; ANTITUMOR ACTIVITIES; EXHIBITS POTENT; MYELOMA; DESIGN; HEAT-SHOCK-PROTEIN-90; TANESPIMYCIN; DERIVATIVES; MECHANISM;
D O I
10.1021/jm300810x
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Alkyne 40, 5-(2-amino-4-chloro-7-((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-2-methylpent-4-yn-2-ol (EC144), is a second generation inhibitor of heat shock protein 90 (Hsp90) and is substantially more potent in vitro and in vivo than the first generation inhibitor 14 (BIIB021) that completed phase II clinical trials. Alkyne 40 is more potent than 14 in an Hsp90 alpha binding assay (IC50 = 1.1 vs 5.1 nM) as well as in its ability to degrade Her-2 in MCF-7 cells (EC50 = 14 vs 38 nM). In a mouse model of gastric tumors (N87), 40 stops tumor growth at 5 mg/kg and causes partial tumor regressions at 10 mg/kg (po, qdx5). Under the same conditions, 14 stops tumor growth only at 120 mg/kg, and does not induce partial regressions. Thus, alkyne 40 is approximately 20-fold more efficacious than 14 in mice.
引用
收藏
页码:7786 / 7795
页数:10
相关论文
共 50 条
  • [31] Phenylarsine oxide is a potent inhibitor of heat shock protein induction in gastric epithelial cells.
    Miyoshi, M
    Rokutan, K
    Teshima, S
    Nikawa, T
    Kishi, K
    Nakamura, K
    GASTROENTEROLOGY, 1998, 114 (04) : A644 - A644
  • [32] Heat shock protein 90 in neurodegenerative diseases
    Luo, Wenjie
    Sun, Weilin
    Taldone, Tony
    Rodina, Anna
    Chiosis, Gabriela
    MOLECULAR NEURODEGENERATION, 2010, 5
  • [33] Heat Shock Protein 90 Inhibitors in Oncology
    Ozgur, Aykut
    Tutar, Yusuf
    CURRENT PROTEOMICS, 2014, 11 (01) : 2 - 16
  • [34] Crowding Activates Heat Shock Protein 90
    Halpin, Jackson C.
    Huang, Bin
    Sun, Ming
    Street, Timothy O.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2016, 291 (12) : 6447 - 6455
  • [35] The heat shock protein 90 of Leishmania donovani
    Wiesgigl, M
    Clos, J
    MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 2001, 190 (1-2) : 27 - 31
  • [36] Heat shock protein 90: a capacitor or a mutator?
    Sawarkar, Ritwick
    Paro, Renato
    JOURNAL OF BIOSCIENCES, 2010, 35 (02) : 163 - 165
  • [37] Heat shock protein 90 inhibition in the endothelium
    Barabutis, Nektarios
    FRONTIERS IN MEDICINE, 2023, 10
  • [38] Heat shock protein 90 antibodies in autism
    M Evers
    C Cunningham-Rundles
    E Hollander
    Molecular Psychiatry, 2002, 7 : S26 - S28
  • [39] Heat shock protein 90 in neurodegenerative diseases
    Wenjie Luo
    Weilin Sun
    Tony Taldone
    Anna Rodina
    Gabriela Chiosis
    Molecular Neurodegeneration, 5
  • [40] Is heat shock protein 90 the cancer chaperone?
    Neckers, Len
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 231